New evidence
In a 5-day ICU trial, Streptococcus salivarius improved oral hygiene scores by nearly 2 points while controls deteriorated — but the results come from a small, specific clinical population
This is among the first controlled studies on this probiotic for oral health, so the finding is promising but far from established — especially since it only applies to critically ill patients on ventilators, not the general public.
A triple-blind randomized trial gave mechanically ventilated ICU patients a Streptococcus salivarius probiotic twice daily for five days. The treatment group's oral health status improved significantly, while the control group's worsened, suggesting the probiotic might help reduce infection risk in this specific setting. However, the study was short and focused on a vulnerable hospital population, so the results don't yet support routine use for healthy people.
Where this fits in the evidence
This is among the first studies we've indexed on Streptococcus salivarius for Improved Oral Health — treat it as an early signal until more research accumulates.
The study
- Randomized Controlled Trial (RCT)
- 2026-02-03
- BMC infectious diseases
This is a plain-language summary of a research finding, not medical advice. Pillser surfaces research signals to help you decide what's worth investigating — always consult a qualified professional before changing what you take.